ArticleMedComm2026

Optimizing Lung-molGPA-Directed Therapy for EGFR/ALK/ROS1-Wildtype Non-Small Cell Lung Cancer Brain Metastases: Survival Outcomes Analysis.

Bin Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.